Indian Journal of Clinical Biochemistry

, Volume 19, Issue 2, pp 149–151 | Cite as

Leucine amino peptidase a better indicator of disseminated malignant disease

  • M. S. Ghadge
  • Raste


Leucine amino peptidase (LAP) activity was studied in serum and urine samples of 25 healthy ambulant subjects, 20 patients with localised and 41 patients with malignant disseminated disease. Serum levels of the enzyme were elevated but not significantly in both localised and disseminated disease whereas the urinary activity of the enzyme was markedly elevated in disseminated disease (p<0.001) as compared to localised disease. This quantitative method used for determination is reliable, accurate, simple, rapid and cost effective and therefore has better application as an indicator of disseminated disease in a clincal setting.


Clinical Biochemistry Testicular Tumor Leucine Aminopeptidase Renal Tubular Secretion Urinary Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arst, H.E., Manning, R.T. and Delp, M. (1959) Serum leucine amino peptidase activity: findings in carcinoma of the pancreas, pregnancy and other disorders. Am. J. Med. Sc. 238, 598–609.CrossRefGoogle Scholar
  2. 2.
    Bressler, R., Forsyth, B.R. and Klatskin, G. (1960) Serum leucine amino peptidase activity in hepatobiliary and pancreatic disease. J. Lab. & Clin. Med. 56, 417–430.Google Scholar
  3. 3.
    Derrick, J.B., Heagy, F.C., Urtasun, R. and Swartz, D.P. (1963) A comparison of the leucine amino peptidase with the hepatoscan in the investigation of suspected liver metastasis. Clin. Chem. 9, 448–449.Google Scholar
  4. 4.
    Sathe, S.B. and Taskar, S.P. (1982) Leucine amino peptidase levels in hepatic and certain gastrointestinal tract cancers. JAPI. 30, 83.PubMedGoogle Scholar
  5. 5.
    Ghadge, M.S., Sirsat, A.V., Bhansali, M.S., Desouza, L.J. and Jagannath, P. (2001) Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas. Ind. J. Clin. Biochem. 16, 60–64.CrossRefGoogle Scholar
  6. 6.
    Szasz, G. (1964) Serum leucine amino peptidase activity in acute lesions of the liver parenchyma. Lancet, i, 441–442.CrossRefGoogle Scholar
  7. 7.
    Khanolkar, M.M., Sirsat, A.V., Deshmane, V.H. and Kamat, M.R. (1992) Serum leucine amino peptidase levels as markers in testicular tumors. Ind. J. Med. Res. 96, 372–375.Google Scholar
  8. 8.
    Szasz, G. (1967) A kinetic photometric method for serum leucine amino peptidase. Am. J. Clin. Path. 47, 607–613.PubMedGoogle Scholar
  9. 9.
    Larsen, K. (1972). Creatinine assay by a reaction kinetic principle. Clin. Chim. Acta 41, 209.PubMedCrossRefGoogle Scholar
  10. 10.
    Phillips, R.W. and Manildi, E.R. (1970) Elevation of leucine amino peptidase in disseminated malignant disease. Cancer, 26, 1006–1012.PubMedCrossRefGoogle Scholar
  11. 11.
    Rutenburg, A.M., Goldberg, J.A. and Pineda, E.P. (1958) Leucine aminopeptidase activity Observations in patients with cancer of pancreas and other diseases. New Engl. J. Med. 259, 469–472.PubMedGoogle Scholar
  12. 12.
    Hoffman, E., Nachlas, M.M., Gaby, S.D., Abrams, S.J. and Seligman, A.M. (1960) Limitations in the diagnostic value of serum leucine aminopeptidase. New Engl. J. Med. 263, 541–544.PubMedGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2004

Authors and Affiliations

  • M. S. Ghadge
    • 1
  • Raste
    • 1
  1. 1.Department of BiochemistryTata Memorial HospitalMumbai

Personalised recommendations